MENU

Fox Chase Cancer Center Earns National Accreditation with Silver Commendation from the Commission on Cancer of the American College of Surgeons

December 12, 2016

PHILADELPHIA (December 12, 2016) – The Commission on Cancer (CoC), a quality  program of the American College of Surgeons (ACS) has granted Three-Year Accreditation with Commendation to Fox Chase Cancer Center. To earn voluntary CoC accreditation, a cancer program must meet or exceed  the CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care. Three-Year Accreditation with Commendation is only awarded to a facility that exceeds standard requirements at the time of its triennial survey. 

         Because it is a CoC-accredited cancer center, Fox Chase takes a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists. This multidisciplinary partnership results in improved patient care. 

         “Retaining this prestigious accreditation is a reflection of the high quality work of our faculty and staff, and our total dedication to providing the best care,” said Richard I. Fisher, president and CEO at Fox Chase.

         The CoC Accreditation Program provides the framework for Fox Chase to improve its quality of patient care through various cancer-related programs that focus on the full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease, and end-of-life care. When patients receive care at a CoC facility, they also have access to information on clinical trials and new treatments, genetic counseling, and patient centered services including psycho-social support, a patient navigation process, and a survivorship care plan that documents the care each patient receives and seeks to improve cancer survivors’ quality of life.  

         Like all CoC-accredited facilities, Fox Chase maintains a cancer registry and contributes data to the National Cancer Data Base (NCDB), a joint program of the CoC and American Cancer Society .This nationwide oncology outcomes database is the largest clinical disease registry in the world.  Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care.  CoC-accredited cancer centers, in turn, have access to information derived from this type of data analysis, which is used to create national, regional, and state benchmark reports.  These reports help CoC facilities with their quality improvement efforts.  

         The American Cancer Society estimates that more than 1.6 million cases of cancer will be diagnosed in 2016. There are currently more than 1,500 CoC-accredited cancer programs in the U.S. and Puerto Rico. CoC-accredited facilities diagnose and/or treat more than 70 percent of all newly diagnosed cancer patients. When cancer patients choose to seek care locally at a CoC-accredited cancer center, they are gaining access to comprehensive, state-of-the-art cancer care close to home. The CoC provides the public with information on the resources, services, and cancer treatment experience for each CoC-accredited cancer program through the CoC Hospital Locator at https://www.facs.org/search/cancer-programs.

         Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care.  Its membership includes Fellows of the American College of Surgeons.  For more information, visit: www.facs.org/cancer

       

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. 
For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Connect with Fox Chase